.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
McKesson
Citi
US Department of Justice
Harvard Business School
Novartis
Chinese Patent Office
Deloitte
Cipla
Julphar

Generated: June 25, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ibrutinib

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pharmacyclics Inc
IMBRUVICA
ibrutinib
CAPSULE;ORAL205552NDAPharmacyclics LLC57962-140-0990 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-09)
Pharmacyclics Inc
IMBRUVICA
ibrutinib
CAPSULE;ORAL205552NDAPharmacyclics LLC57962-140-12120 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-12)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Fish and Richardson
Farmers Insurance
Queensland Health
Cerilliant
Novartis
Federal Trade Commission
Medtronic
Colorcon
McKinsey

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot